Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of injectable JMKX003142 for fluid retention caused by heart failure
CTR20251510Phase 2Completed
- Sponsor
- Zhejiang Hangyu Pharmaceutical
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JMKX003142 in heart failure (HF), sponsored by Zhejiang Hangyu Pharmaceutical. Started Jul 2025; status: completed.
02
Drugs
JMKX003142
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on CTR20251510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251510.